NasdaqHealth CareHealth Care TechnologyS&P SmallCap 600
$28.89
-0.71 (-2.40%)
Close of Nov 06, 2026 · end-of-day data
HSTM 8-K filings in 2025
Every material Form 8-K HealthStream filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
HealthStream reported third-quarter 2025 revenue of $76.5 million, up 4.6%, and net income of $6.1 million, up 6.3%, with diluted EPS of $0.20 versus $0.19 a year earlier. The company narrowed its full-year 2025 guidance ranges, with revenue now expected at $299.5 million to $301.5 million, versus the prior $297.5 million to $303.5 million, while the midpoints of the revenue, net income and adjusted EBITDA ranges are unchanged.
Q3 2025 revenue was $76.5 million, up from $73.1 million; operating income rose 16.5% to $7.6 million.
Full-year 2025 revenue guidance is $299.5 million to $301.5 million; adjusted EBITDA guidance is $69.5 million to $71.5 million.
The Board declared a quarterly dividend of $0.031 per share, payable November 28, 2025 to holders of record on November 17, 2025.
The Virsys12 acquisition closed October 8, 2025, for $13.0 million in cash plus up to $4.0 million contingent on performance.
HealthStream reported second-quarter 2025 revenue of $74.4 million, up 4.0% and a company record, with net income of $5.4 million, up 29.3%, and diluted EPS of $0.18 versus $0.14 a year earlier. The company raised its 2025 net income guidance to $19.5 million-$22.4 million from $18.6 million-$21.0 million, and the board declared a $0.031 quarterly dividend.
Q2 2025 revenue was $74.4 million, up from $71.6 million in Q2 2024, a company record for quarterly revenue.
Q2 2025 net income was $5.4 million and diluted EPS was $0.18, compared with $4.2 million and $0.14 in Q2 2024.
Full-year 2025 net income guidance was raised to $19.5 million-$22.4 million from $18.6 million-$21.0 million; revenue guidance is $297.5 million-$303.5 million.
The board declared a $0.031 per share dividend payable August 29, 2025, to holders of record on August 18, 2025; the $25.0 million buyback program was completed in July.
HealthStream reported first-quarter 2025 revenue of $73.5 million, up 1.0%, but net income fell 17.1% to $4.3 million and diluted EPS fell to $0.14 from $0.17. The company lowered its 2025 revenue, net income and adjusted EBITDA guidance, citing technology scaling issues with CredentialStream and macroeconomic conditions affecting renewals and purchasing, so shareholders face higher revenue alongside lower profit and a reduced outlook.
Q1 2025 revenue of $73.5 million, up 1.0% from $72.8 million; net income of $4.3 million, down 17.1% from $5.2 million
Diluted EPS of $0.14 versus $0.17 a year earlier; operating income of $4.4 million, down 23.1%
2025 revenue guidance cut to $297.5 million to $303.5 million from $302.0 million to $307.0 million
2025 adjusted EBITDA guidance lowered to $68.5 million to $72.5 million from $70.0 million to $74.0 million; quarterly dividend of $0.031 per share payable May 30, 2025
HealthStream director William W. Stead, M.D. told the company on March 24, 2025 that he will not stand for re-election as a Class I director and will retire from the Board at the upcoming annual stockholder meeting. The filing states the decision is not the result of any disagreement with the company. The change is a routine board transition that does not alter company financial results or guidance.
Dr. William W. Stead, M.D. notified the company on March 24, 2025 of his decision
He will not stand for re-election as a Class I director at the annual stockholders meeting
His retirement from the Board takes effect concurrently with that annual meeting
The filing states the departure is not the result of any disagreement with the company
HealthStream appointed Charles E. Beard, Jr. to its Board of Directors effective March 7, 2025, with a Class I term expiring at the 2028 annual meeting. He is also expected to serve on the Board's Audit Committee. The filing describes a board addition and does not report any change in financial results or guidance.
Board appointment effective March 7, 2025; Class I director with term expiring at the 2028 annual meeting
Expected to serve on the Audit Committee
Beard retired in December 2024 as Chief Operating Officer at Guidehouse
Filing states no related-party transactions requiring disclosure under Item 404(a)
HealthStream disclosed that Executive Vice President Michael Sousa will resign effective March 31, 2025, and that three executives were promoted to EVP roles, including Michael Collier, Trisha Coady and Kevin O'Hara. Each promoted executive received performance-based RSUs with a grant date fair value of approximately $400,000, approved by the Compensation Committee on February 27, 2025. The changes were previously announced in the February 24, 2025 earnings release.
Michael Sousa, EVP Enterprise Applications, intends to resign effective March 31, 2025
Michael Collier promoted to EVP, Corporate Strategy, Development & Operations; Trisha Coady to EVP, Workforce Development Solutions; Kevin O'Hara to EVP, Enterprise Workforce Platform
Each promotion includes performance-based RSUs with grant date fair value of approximately $400,000, vesting in increments over 2026 to 2030, plus base salary increases
HealthStream reported fourth-quarter and full-year 2024 results with higher revenue, net income and EPS compared with 2023, and gave 2025 guidance calling for revenue of $302.0 million to $307.0 million and adjusted EBITDA of $70.0 million to $74.0 million. The company also declared a quarterly dividend of $0.031 per share, up 10.7% from $0.028, and announced executive promotions and the planned departure of EVP Michael Sousa at the end of the first quarter of 2025.
Q4 2024 revenue was $74.2 million, up 5.2%; diluted EPS was $0.16 versus $0.15 a year earlier.
Full-year 2024 revenue was $291.6 million, up 4.5%; net income was $20.0 million, up 31.5%, and diluted EPS was $0.66 versus $0.50.
2025 guidance: revenue $302.0 million to $307.0 million; net income $19.2 million to $21.4 million; adjusted EBITDA $70.0 million to $74.0 million.
Quarterly dividend of $0.031 per share is payable March 21, 2025 to holders of record on March 10, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every HealthStream filing is on SEC EDGAR ↗. 8-K briefs of other companies →